OPKO Health (OPK) Reports Q1 Earnings: What Key Metrics Have to Say

For the quarter ended March 2025, OPKO Health (OPK) reported revenue of $149.9 million, down 13.7% over the same period last year. EPS came in at -$0.10, compared to -$0.12 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $164.48 million, representing a surprise of -8.87%. The company delivered an EPS surprise of -66.67%, with the consensus EPS estimate being -$0.06.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how OPKO Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Revenues- Revenue from services: $102.80 million versus $102.66 million estimated by six analysts on average. Compared to the year-ago quarter, this number represents a -19% change.
• Revenues- Revenue from transfer of intellectual property and other: $12.30 million versus $22.16 million estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +41.4% change.
• Revenues- Revenue from products: $34.80 million versus $39.64 million estimated by six analysts on average. Compared to the year-ago quarter, this number represents a -8.7% change.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research